Local generic drug company is 1 of 6 accused by 20 states in price-fixing lawsuit - Philadelphia Business Journal
TEVA Stock Surges 24% as Teva Pharmaceuticals Settles Lawsuits | InvestorPlace
Teva found liable for fueling opioid addiction in New York | Mint
Teva To Pay Up To $3.6 Billion In US Opioid Settlement
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
New details in Big Pharma price-fixing lawsuit suggest lawyers wrote 'polite f-u letters' | BenefitsPRO
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Report: Teva settles investor lawsuit for $420M - www.israelhayom.com
Teva settles shareholder lawsuit over generic drug | Business Insurance
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Drugmaker Teva reaches opioid settlements worth $4.3 billion involving multiple states | Health News Florida
Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Teva proposes settlement in US opioid lawsuits | Israel National News - Arutz Sheva
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva may move court against Dr Reddy's for patent infringement | Mint
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva at the center of a lawsuit for raising drug prices - The Jerusalem Post
Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters
Attorney General Morrisey sues opioid makers Johnson & Johnson, Teva Pharmaceuticals | WBOY.com
